What is the clinical significance of detecting lipoprotein(a) in lipid testing?

• A. Elevated Lp(a) is a genetic risk factor for ASCVD and is responsive to statins.
• B. Lp(a) levels directly reflect liver function and are used to monitor hepatic disease.
• C. Elevated Lp(a) is an independent genetic risk factor for ASCVD and is relatively resistant to standard lipid-lowering therapy.
• D. Lp(a) testing is primarily used to diagnose diabetes.

Answer: (C)

Lipoprotein(a) is an inherited lipoprotein particle that adds cardiovascular risk beyond traditional lipids. Its levels are largely determined by the LPA gene and are not meaningfully changed by most standard lipid-lowering therapies, so a high Lp(a) represents a persistent, genetic risk for atherosclerotic disease even when LDL-C is controlled.

This is why detecting Lp(a) is clinically significant: it identifies an independent risk factor for ASCVD that can influence risk stratification and management. While statins and many other lipid drugs poorly affect Lp(a), some therapies (like certain PCSK9 inhibitors and emerging antisense approaches) can lower it, but the general point remains that Lp(a) is relatively resistant to routine lipid-lowering therapy. It is not a marker of liver function or hepatic disease, and it is not used to diagnose diabetes.